Class II transactivator restricts viral replication, extending its effect to HBV: Editorial on “Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction”

키워드

참고문헌 (20)

1. Reith W, "Regulation of MHC class II gene expression by the class II transactivator", Nat Rev Immunol, 5, pp.793~806 (2005)
2. León Machado JA, "The MHC class II transactivator CIITA : Not(Quite)the odd-one-out anymore among NLR proteins", Int J Mol Sci, 22, pp.1074~ (2021)
3. Xie XW, "Expression of CIITA-related MHCII molecules in tumors linked to prognosis in hepatocellular carcinoma", Int J Oncol, 34, pp.681~688 (2009)
4. Dezhbord M, "Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction", Clin Mol Hepatol, 30, pp.539~560 (2024)
5. Sandhu PK, "Human cytomegalovirus decreases major histocompatibility complex class II by regulating class II transactivator transcript levels in a myeloid cell line", J Virol, 94, pp.e01901-19~ (2020)
6. Miller DM, "Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak", Stat pathway, 1998, pp.187, 675~683
7. Balan N, "Repression of CIITA by the Epstein-Barr virus transcription factor Zta is independent of its dimerization and DNA binding", J Gen Virol, 97, pp.725~732 (2016)
8. Cai Q, "IRF-4-mediated CIITA transcription is blocked by KSHV encoded LANA to inhibit MHC II presentation", PLoS Pathog, 9, pp.e1003751~ (2013)
9. Saito K, "Hepatitis C virus inhibits cell surface expression of HLA-DR, prevents dendritic cell maturation, and induces interleukin-10 production", J Virol, 82, pp.3320~3328 (2008)
10. Pannhorst K, "The non-classical major histocompatibility complex II protein SLA-DM is crucial for African swine fever virus replication", Sci Rep, 13, pp.10342~ (2023)
11. Girona-Alarcon M, "Low levels of CIITA and high levels of SOCS1 predict COVID-19 disease severity in children and adults", iScience, 25, pp.103595~ (2022)
12. Bruchez A, "MHC class II transactivator CIITA induces cell resistance to Ebola virus and SARS-like coronaviruses", Science, 370, pp.241~247 (2020)
13. Kanazawa S, "Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection", Immunity, 12, pp.61~70 (2000)
14. Forlani G, "The MHC-II transactivator CIITA inhibits Tat function and HIV-1 replication in human myeloid cells", J Transl Med, 14, pp.94~ (2016)
15. Forlani G, "The MHC-II transactivator CIITA, a restriction factor against oncogenic HTLV-1and HTLV-2 retroviruses : similarities and differences in the inhibition of Tax-1 and Tax-2 viral transactivators", Front Microbiol, 4, pp.234~ (2013)
16. Forlani G, "The major histocompatibility complex class II transactivator CIITA inhibits the persistent activation of NF-κB by the human T cell lymphotropic virus type 1 Tax-1 oncoprotein", J Virol, 90, pp.3708~3721 (2016)
17. Casoli C, "The MHC class II transcriptional activator(CIITA)inhibits HTLV-2 viral replication by blocking the function of the viral transactivator Tax-2", Blood, 103, pp.995~1001 (2004)
18. Tosi G, "Inhibition of human T cell leukemia virus type 2 replication by the suppressive action of class II transactivator and nuclear factor Y", Proc Natl Acad Sci U S A, 103, pp.12861~12866 (2006)
19. Kim SW, "Toward a complete cure for chronic hepatitis B : Novel therapeutic targets for hepatitis B virus", Clin Mol Hepatol, 28, pp.17~30 (2022)
20. Mak LY, "The role of different viral biomarkers on the management of chronic hepatitis B", Clin Mol Hepatol, 29, pp.263~276 (2023)

관련 논문AI추천